BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9524240)

  • 21. Phenobarbital-dependent protein binding to Barbie box-like sequences in the coding region of cytochrome P450BM-3 gene from Bacillus megaterium.
    Gaidamakova EK; Alpatov OV; Ischenko IV; Kovalenko SP; Lyakhovich VV
    Gene; 1996 Dec; 183(1-2):97-101. PubMed ID: 8996092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages.
    Huang KC; Chen CW; Chen JC; Lin WW
    J Biomed Sci; 2003; 10(4):396-405. PubMed ID: 12824699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types.
    Nègre-Aminou P; van Vliet AK; van Erck M; van Thiel GC; van Leeuwen RE; Cohen LH
    Biochim Biophys Acta; 1997 Apr; 1345(3):259-68. PubMed ID: 9150246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxylation of Compactin (ML-236B) by CYP105D7 (SAV_7469) from
    Yao Q; Ma L; Liu L; Ikeda H; Fushinobu S; Li S; Xu LH
    J Microbiol Biotechnol; 2017 May; 27(5):956-964. PubMed ID: 28274099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional derepression of the murine Cyp1a-1 gene by mevinolin.
    Puga A; Raychaudhuri B; Nebert DW
    FASEB J; 1992 Jan; 6(2):777-85. PubMed ID: 1311272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia.
    Haba T; Mabuchi H; Yoshimura A; Watanabe A; Wakasugi T; Tatami R; Ueda K; Ueda R; Kametani T; Koizumi J; Miyamoto S; Takeda R; Takeshita H
    J Clin Invest; 1981 May; 67(5):1532-40. PubMed ID: 7229037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional activation of cytochrome P450 CYP2C45 by drugs is mediated by the chicken xenobiotic receptor (CXR) interacting with a phenobarbital response enhancer unit.
    Baader M; Gnerre C; Stegeman JJ; Meyer UA
    J Biol Chem; 2002 May; 277(18):15647-53. PubMed ID: 11867618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amylase and chitinase genes in Streptomyces lividans are regulated by reg1, a pleiotropic regulatory gene.
    Nguyen J; Francou F; Virolle MJ; Guérineau M
    J Bacteriol; 1997 Oct; 179(20):6383-90. PubMed ID: 9335287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenobarbital and sulfonylurea-inducible operons encoding herbicide metabolizing cytochromes P-450 in Streptomyces griseolus.
    Patel NV; Omer CA
    Gene; 1992 Mar; 112(1):67-76. PubMed ID: 1551600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of simvastatin and pravastatin on 6 beta-hydroxycortisol excretion, a potential marker of cytochrome P-450 3A.
    Horsmans Y; Desager JP; van den Berge V; Abrassart M; Harvengt C
    Pharmacol Res; 1993; 28(3):243-8. PubMed ID: 8108314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of hepatic lanosterol 14 alpha-demethylase gene expression by dietary cholesterol and cholesterol-lowering agents.
    Ness GC; Gertz KR; Holland RC
    Arch Biochem Biophys; 2001 Nov; 395(2):233-8. PubMed ID: 11697861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering of a hybrid biotransformation system for cytochrome P450sca-2 in Escherichia coli.
    Ba L; Li P; Zhang H; Duan Y; Lin Z
    Biotechnol J; 2013 Jul; 8(7):785-93. PubMed ID: 23744742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
    Carmena R
    Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284
    [No Abstract]   [Full Text] [Related]  

  • 36. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
    Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grapefruit juice-lovastatin interaction.
    Bailey DG; Dresser GK
    Clin Pharmacol Ther; 2000 Jun; 67(6):690. PubMed ID: 10872652
    [No Abstract]   [Full Text] [Related]  

  • 38. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
    Neuvonen PJ; Kantola T; Kivistö KT
    Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The phenobarbital-induced transcriptional activation of cytochrome P-450 genes is blocked by the glucocorticoid-progesterone antagonist RU486.
    Shaw PM; Adesnik M; Weiss MC; Corcos L
    Mol Pharmacol; 1993 Oct; 44(4):775-83. PubMed ID: 8232228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the specific sequence recognized by Penicillium citrinum MlcR, a GAL4-type transcriptional activator of ML-236B (compactin) biosynthetic genes.
    Baba S; Nihira T; Hosobuchi M
    Fungal Genet Biol; 2008 Sep; 45(9):1277-83. PubMed ID: 18667169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.